About
Dr. Hermiston is Vice President, Biologics Research, U.S. Innovation Center Site Head for Bayer HealthCare Pharmaceuticals. Dr. Hermiston leads the US biologics research team at Bayer's world-wide pharmaceutical research organization and oversees the operation of Bayer's West Coast research center. With a biotechnology career spanning nearly two decades, Dr. Hermiston has published more than 50 research papers and reviews and holds over 10 patents. Prior to joining Bayer, Dr. Hermiston was the scientific director for the global department of gene therapy research and gene technologies for Berlex Biosciences and its Germany-based parent company, Schering AG. Dr. Hermiston also served in roles of increasing responsibility with Onyx Pharmaceuticals and completed a National Institutes of Health (NIH) fellowship in microbiology and immunology at St. Louis University School of Medicine. Dr. Hermiston holds a Ph.D. in molecular virology from the University of Iowa and a bachelor's degree
Position in the VCSift Database
- • 579 investors hold the CEO & Founder role in VCSift. Terry Hermiston is one of them.
- • 1,751 investors are based in California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- California, US
Contact Information
Find more investors like Terry
Search Investors